Search Results 621-630 of 19240 for alzheimers
“Alzheimer's disease is an epidemic affecting 35 million people worldwide,” says Dr. Ertekin-Taner. “It's going to escalate unless we can stop it or slow it ...
Mayo Clinic has proposed a new model for mapping the symptoms of Alzheimer's disease to brain anatomy. Developed by applying machine learning to patient ...
Ronald Petersen, M.D., a neurologist and director of Mayo Clinic's Alzheimer's Disease Research Center, says you can't prevent dementia, but you can reduce ...
The purpose of this study is to evaluate the effectiveness and safety of gantenerumab versus placebo in participants with early (prodromal to mild) Alzheimer's ...
Research shows as many as 1 in 5 people age 65 and older will develop mild cognitive impairment. Many of those will progress to Alzheimer's disease. But the new ...
Gait disturbances linked with decline in cognitive function · Researchers refine guidelines designed to identify Alzheimer's early · Mayo Clinic Alzheimer's ...
... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.
... Alzheimer's disease and be used as a diagnostic test for Alzheimer's disease; examining differences in dementia between African-Americans and Caucasians ...
... Alzheimer's disease showing amyloid-beta plaques. Brain amyloid plaques and gliosis. Section from the brain of a mouse model of Alzheimer's disease showing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.